Viking Therapeutics Shares Plunge on Clinical Trial Safety Concerns
Shares of Viking Therapeutics, Inc. (VKTX) experienced a dramatic sell-off, collapsing 42% following the release of new data for its...
Accomplished economist, entrepreneur, and profound expert in financial markets.
Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.
Shares of Viking Therapeutics, Inc. (VKTX) experienced a dramatic sell-off, collapsing 42% following the release of new data for its...
A pivotal figure in industrial software development, Zhou Ming, has left Altair Engineering Inc. in a move that underscores the...
While much of the investment community remains fixated on technology giants and artificial intelligence trends, a regional banking institution from...
Oracle Corporation is executing a dramatic corporate overhaul that has sent shockwaves through investor circles. The technology giant is implementing...
Warren Buffett's Berkshire Hathaway made a surprise move into UnitedHealth Group, acquiring a $1.6 billion stake that ignited the stock's...
Appian has announced a major update to its platform, introducing a suite of advanced features designed to deliver more intelligent...
While market analysts maintain divergent views on Inspire Medical Systems, a significant institutional investor has placed a substantial vote of...
The once-bright growth narrative for telehealth provider Hims & Hers is showing significant cracks. Market experts are now raising fundamental...
Recent regulatory filings reveal a split in institutional sentiment toward Trustmark Corporation (TRMK) shares during Q1. While Vanguard Group Inc....
Ligand Pharmaceuticals is set to enhance its communication with the investment community through a series of high-profile engagements this September....
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.